Year: 2020
Type: review
Abstract: Because of a loss-of-function mutation in the GGTA1 gene, humans are unable to synthetize α1,3-Galactose (Gal) decorated glycans and develop high levels of circulating anti-α1,3-Galactose antibodies (anti-Gal Abs). Anti-Gal Abs have been identified as a major obstacle of organ xenotransplantation responsible for hyperacute vascular rejection and delayed vascular insult, and play a role in several host-pathogen relationships including potential susceptibility to infection. Anti-Gal Abs are supposed to stem from immunization against the gut microbiota, an assumption derived from the observation that some pathogens display α1,3-Gal and that antibiotic treatment decreases the level of anti-Gal. However, there is little information to date concerning the microorganisms producing α1,3-Gal in the human gut microbiome. Here, available α1,3-Galactosyltransferase gene sequences from gut bacteria were selectively quantified for the first time in the gut microbiome shotgun sequences of 163 adult individuals from 2 published population-based metagenomics analyses. We showed that most of the gut microbiome of adult individuals contained a small set of bacteria able to synthetize the α1,3-Gal antigen. The Enterobacteriaceae family, including Escherichia coli, was found to be the major source of the α1,3-Gal antigen, which was also produced by Pasteurellaceae genera, Haemophilus influenza, and Lactobacillus species.
Source: Frontiers in Immunology
Authors: Emmanuel Montassier, Gabriel A. Al-Ghalith, Camille Mathé, Quentin Le Bastard, Venceslas Douillard, Abel Garnier, Rémi Guimon, Bastien Raimondeau, Yann Touchefeu, Emilie Duchalais, Nicolas Vince, Sophie Limou, Pierre-Antoine Gourraud, David A. Laplaud, Arnaud B. Nicot, Jean-Paul Soulillou, Laureline Berthelot
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,482
OpenAlex ID: W2999232642
